CYPH
NASDAQ · Biotechnology
Cypherpunk Technologies Inc
$1.19
+0.13 (+12.26%)
Open$1.06
Previous Close$1.06
Day High$1.21
Day Low$1.05
52W High$3.70
52W Low$0.23
Volume—
Avg Volume5.66M
Market Cap99.43M
P/E Ratio20.62
EPS$-0.60
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+3,153.8% upside
Current
$1.19
$1.19
Target
$38.72
$38.72
$25.17
$38.72 avg
$55.57
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 17.60M | 17.28M | 16.86M |
| Net Income | 2.07M | 2.55M | 2.09M |
| Profit Margin | 11.8% | 14.8% | 12.4% |
| EBITDA | 4.18M | 3.81M | 3.82M |
| Free Cash Flow | 1.52M | 982.4K | 1.03M |
| Rev Growth | +11.2% | +9.6% | +9.9% |
| Debt/Equity | 0.55 | 0.54 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |